๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants

โœ Scribed by C.-J. Liu; J.-H. Kao; P.-J. Chen; T.-C. Chen; F.-Y. Lin; M.-Y. Lai; D.-S. Chen

Book ID
108885863
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
78 KB
Volume
13
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Liver transplantation for chronic hepati
Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine
โœ Chung Mau Lo; Chi Leung Liu; George K. Lau; See Ching Chan; Irene O. Ng; Sheung ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 95 KB

Lamivudine treatment in patients with chronic hepatitis B virus (HBV) infection may improve clinical state and suppress viral replication before liver transplantation. Emergence of lamivudine-resistant YMDD mutant is common. We report the results of liver transplantation in 16 patients with pretrans

Efficacy of entecavir in patients with c
Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone
โœ Ju Hyun Shim; Dong Jin Suh; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Young-Hwa C ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 287 KB ๐Ÿ‘ 1 views

Entecavir (ETV) is currently recommended as a rescue therapy purely for adefovir (ADV)resistant chronic hepatitis B virus (HBV) infections. We evaluated the efficacy of ETV in patients who were resistant to lamivudine (LAM)/ADV sequential therapy and in those resistant to LAM monotherapy. Fifty LAM/